Kellie Jones, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1890 Goodman Rd E Ste 10, Southaven, MS 38671 Phone: 662-772-5882 |
Dr. Jonathan William Wilson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1890 Goodman Rd E Ste 100, Southaven, MS 38671 Phone: 662-772-5882 |
Southaven Vision Center, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 484 Church Rd., Southaven, MS 38671 Phone: 662-349-3737 Fax: 662-349-2828 |
News Archive
"This January marks the first anniversary of the London Declaration on Neglected Tropical Diseases - a coordinated effort by endemic countries, non-governmental organizations, drug companies, and donors to improve the lives of more than a billion of the world's poorest people by the end of the decade," a Lancet editorial writes.
Boehringer Ingelheim today announced the submission of an application to the European Medicines Agency (EMA) for use of Pradaxa (dabigatran etexilate) for the treatment of acute deep vein thrombosis (DVT) and pulmonary embolism (PE) and the prevention of recurrent DVT and PE.
Employers in the United States have become less satisfied with their health insurers, according to a study released today by PricewaterhouseCoopers' Health Research Institute. Hit hard by the recession, employers of all sizes are taking a critical look at their health benefits strategy and the value they derive from it. They are looking to their health plan providers for information, technology and strategies to help reduce waste in healthcare spending and better engage employees in managing their health.
Doses of medicine 100,000 times smaller than the diameter of a human hair prevent the tissue damage associated with atherosclerosis and other chronic diseases in mice.
The world's most significant coronavirus disease (COVID-19) vaccine study is underway in the United States, with a planned 30,000 volunteers. The phase 3 clinical trial aims to examine the efficacy and safety of the candidate vaccine developed by the National Institutes of Health and Moderna Inc.
› Verified 3 days ago